Comparison

CRANAD 2 European Partner

Item no. TMO-T22694-1mg
Manufacturer TargetMol
CASRN 1193447-34-5
Amount 1 mg
Quantity options 100 mg 10 mg 1 mg 200 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 98.53%
Citations Jara-Guajardo P , Cabrera P , Celis F , et al. Gold Nanoparticles Mediate Improved Detection of beta-amyloid Aggregates by Fluorescence[J]. Nanomaterials, 2020, 10(4).
Smiles CN(C)c1ccc(\C=C\C(=O)\C=C(/OB(F)F)\C=C\c2ccc(cc2)N(C)C)cc1
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias 1193447-34-5
Shipping Condition Cool pack
Available
Manufacturer - Targets
Others
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
410.27
Description
CRANAD-2 is a difluoroboron-derivatized curcumins as near-infrared probe for in vivo detection of amyloid-beta deposits. Upon interacting with Abeta aggregates, CRANAD-2 undergoes a range of changes, which include a 70-fold fluorescence intensity increase, a 90 nm blue shift (from 805 to 715 nm), and a large increase in quantum yield.
Pathways
Others

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close